Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer research from X. Pivot and colleagues discussed
July 24th, 2008
According to a study from Besancon, France, "Natural epothilones and their analogs promote tumor cell death by binding to tubulin and stabilizing microtubules, causing cell death." "Ixabepilone (BMS-247550, Ixempra (R)) is an epothilone analog that optimizes the properties naturally observed with epothilone B. To provide an overview of the results achieved by ixabepilone in metastatic breast cancer. A PubMed search was performed to provide an extensive review of all published data on ixabepilone, in addition to all data reported from international congresses, from 2003 to 2007," wrote X. Pivot and colleagues. The researchers concluded: "There is a...
Source: Women's Health Weekly (2008-07-24)
|
